EPISODE · Sep 15, 2023 · 14 MIN

The Future of MGD Treatment

from Let’s Talk Ophthalmology: an Evolve Medical Education Podcast · host Evolve Medical Education, LLC

John D. Sheppard, MD, MMSc, FACS, speaks about the future of pharmacological therapy for dry eye disease associated with meibomian gland dysfunction. This program was recorded prior to the approval of perfluorohexyloctane ophthalmic solution (formerly known as NOV03). This activity is supported by an unrestricted educational grant from Bausch + Lomb. Click here to view Dr. Sheppard's webinar event, which includes images from the talk. Want to register with Evolve Medical Education? Click here.

Episode metadata supplied by the publisher feed · Published Sep 15, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

The Future of MGD Treatment

0:00 14:40

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Let’s Talk Ophthalmology: an Evolve Medical Education Podcast?

This episode is 14 minutes long.

When was this Let’s Talk Ophthalmology: an Evolve Medical Education Podcast episode published?

This episode was published on September 15, 2023.

Can I download this Let’s Talk Ophthalmology: an Evolve Medical Education Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!